-
- 2023
-
- 06
- • [CartiZol] Obtained marketing auth
• Begin B2C business with official launching of 'Oligochak glutathione film'
• [CartiSeal] officially launched and marketed
- 01
- • [CartiZol] Prime officially launched and marketed
-
- 2022
-
- 09
- • [CartiZol] Extra Signed a sales contract with LG Chem
- 05
- • [CartiFill] Obtained medical device marketing approval from the Health Sciences Authority (HSA) of Singapore and the Thai Food and Drug Administration (Thai FDA)
- 01
- • Registered as a venture business
-
- 2021
-
- 06
- • [CartiZol] officially launched and marketed
- 04
- • [CartiZol] Passed New Health Technology Assessment (NECA)
-
- 2020
-
- 11
- • ISO 13485:2016 (Quality Management System) certified
-
- 2019
-
- 05
- • National health insurance coverage for [Chondron] expanded, groundbreaking ceremony for ‘RMS CAMP’ and proclamation ceremony for ‘RMS Innovation 2028’ global vision held
-
- 2018
-
- 06
- • [Chondron] kicked off Phase 3 clinical trials in Japan, ‘Regenerative Medical System Center for Innovation’ established
-
- 2017
-
- 06
- • Selected as one of 52 delegation to accompany the President's visit to the White House
- 05
- • 'ATELOCOLLAGEN-D.F.' registered in FDA DMF (Drug Master Files)
- 04
- • [RegenPatch] gained marketing approval from the Ministry of Food and Drug Safety (MFDS) of Korea
• Selected as ‘2016 Biopharmaceutical Industrial Development Contribution Corporation’ and awarded the ‘Minister of Health and Welfare Accolade’
- 03
- • 'Theraform-D' preclinical research conducted jointly with Columbia University
-
- 2016
-
- 05
- • 'ATELOCOLLAGEN-D.F.' registered in ICID (International Cosmetic Ingredient Dictionary and Handbook) of PCPC (The Personal Care Products Council)
- 01
- • [CartiZol] acquried NET (New Excellent Technology) cert.
-
- 2015
-
- 12
- • High concentration [BioCollagen] patent registered in Korea (‘High concentration collagen production method’ / Reg. No.: 10-1576060)
- 01
- • [RegenSeal] officially launched and marketed
-
- 2014
-
- 12
- • ISO22716 (Cosmetic GMP - Quality System Management) obtained
- 11
- • High concentration BioCollagen filler [LUCIZEN] marketing approval received from MFDS
• Prime Minister's Commendation received on the 28th 'Day of Medicine' (hosted by Korean Pharmaceutical Association)
- 07
- • ‘BioCollagen Powder’ listed in DMF (FDA)
- 04
- • Received the Presidential award on the 42nd World Health Day (Ministry of Health and Welfare)
- 02
- • [CartiFill] officially launched and marketed
- 01
- • [CartiFill] received HTA (Health Technology Assessment) approval from NECA(National Evidence-based Healthcare Collaboration Agency)
-
- 2013
-
- 06
- • [CartiZol]·[RegenSeal] marketing approval obtained
- 03
- • [CartiFill] marketing approval received
• RMS Phytostem Panax Ginseng, SCE Phytostem Camellia Sinensis and SCE Phytostem Solanum Lycoperscium registered in ICID of PCPC
-
- 2012
-
- 09
- • [TheraFill] marketing approval received in Argentina by ANMAT
• Gel-type [Chondron] received HTA approval from Ministry of Health and Welfare
- 01
- • [BabyCell] approved for private cord blood banking service by Ministry of Health and Welfare
• [OssFill]·[SurgiFill] marketing approval received
-
- 2011
-
- 09
- • [TheraForm] marketing approval
• [OssFill (Biomimetic Bone Supplement)] CE MDD approval
-
- 2010
-
- 05
- • [TheraFill] officially launched and marketed
-
- 2009
-
- 11
- • CE mark obtained for [CartiFill], [DuoFill], [MRM Kit] and [SurgiFill]
- 08
- • [RMS Ossron] marketing approval received
-
- 2008
-
- 05
- • [BioCollagen] registered in ICID (PCPC)
• Held [Chondron] surgical training workshop for the Royal National Orthopaedic Hospital (RNOH) in England
- 04
- • [BioCollagen] registered in DMF (FDA)
-
- 2007
-
- 12
- • Designated as ATC (Advanced Technology Center) by Ministry of Commerce, Industry and Energy
- 10
- • BioCollagen wound healing dressing [TheraForm] received CE approval
-
- 2006
-
- 12
- • ISO13485 certification received
- 11
- • [BioCollagen] filler manufacturing facility construction complated (Seongsu production facility)
-
- 2005
-
- 10
- • [RMS Ossron] received 2005 New Technology Korea Excellence Award (Ministry of Commerce, Industry and Energy)
-
- 2004
-
- 03
- • [Chondron] received IR52 Jang Young Sil award and obtained KT (Excellent Korean Technology) certification
-
- 2003
-
- 12
- • [RMS Ossron] Selected as the next generational world-class product by Ministry of Commerce, Industry and Energy (2003)
- 10
- • [Chondron] awarded the silver medal from 2003 New Technology Korea
-
- 2002
-
- 07
- • [BabyCell] cord blood bank service launched
- 03
- • [Chondron] listed on national health insurance coverage
-
- 2001
-
- 02
- • Facility KGMP certified
- 01
- • [Chondron], Autologous Chondrocyte Implantation, approved as the first bioengineering product
-
- 2000
-
- 04
- • Regenerative Medical System division and cell therapy production facility established
-
- 1996
-
- 04
- • Tissue Engineering Research Association established